Identifying depression is critical to minimizing patient distress, but despite treatment advances, excess mortality persists, says RGA's Akhilesh Pandey. He discusses the disease process, treatment and prognosis, and underwriting implications in On the Risk, the Journal of the Academy of Life Underwriters.
As today’s medical and technological advances continue to be utilized and applied to Diabetes mellitus (DM), a newer and even more complex framework for the disease is emerging, which may help us further our understanding of it. RGA's Dr. Karneen Tam explores the most recent classification update and some of the newer thinking emerging about DM in Reinsurance News.
Marfan’s syndrome is a systemic connective tissue disease that is inherited. It is characterized by abnormalities of the skeletal, cardiovascular and ocular systems predominantly.
Underwriting practices today are a world away from those commonplace 20 years ago, but the biggest evolution is yet to come.
Epigenetics can uncover how poor health habits can affect future wellness and is being viewed as a potentially powerful underwriting tool.
There are few things that contribute more to building an appreciation for different roles than sitting in someone else’s shoes.
While there is yet no HIV vaccine, a small blue pill can prevent HIV transmission. RGA explores the power of PrEP (pre-exposure prophylaxis) as an effective prevention strategy, as well as potential risks, protocols, and barriers to greater use.
The improvement in cancer survival rates has led to a growing life insurance need for cancer survivors worldwide. To mark World Cancer Day, Manuel Plisson, SCOR Global Life Head of Inclusive Underwriting & Medical Expertise, discusses an inclusive rating approach that could help address this protection gap.
Aerosol biopsy is intended to simplify the process of diagnosing major lung diseases by capturing and testing expelled droplets from the lungs.
